Form D · Biotechnology
Link Medicine Corp
Cambridge, MA · CIK 0001324758
Offering snapshot reported Apr 20, 2011 · SEC filing
- Reported sold
- $4.81M Offering amount: $4.81M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 7, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 20, 2011 | Initial | $4,808,500 | No comparison | 16 | SEC filing |
| Apr 30, 2010 | Initial | $20,000,003 | No comparison | 9 | SEC filing |
| Sep 29, 2008 | Initial | $40,000,000 | No comparison | Not reported | SEC filing |
| Jan 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 26, 2006 | Paper | Not reported | No comparison | Not reported | |
| Nov 4, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 22, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-158672
Source: Form D, filed Apr 20, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John F. Dee | Director, Executive |
| Michael E. Fitzgerald | Executive |
| David Frankel | Director |
| Nick Galakatos | Director |
| David Guyer | Director |
| Peter T. Lansbury | Executive |
| David Neafus | Executive |
| R. Michael Poole | Executive |
| Adam J. Rosenberg | Director, Executive |
| Michael Ross | Director |
| Edward Scolnick | Director |
| Michael E. Solomon | Executive |
| Scott Young | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
161 First Street Suite 2 B
Cambridge, MA, 02142
Cambridge, MA, 02142